EMBC News and Press, Embecta Corp. From 02/14/23

Embecta Corp. (EMBC) Q1 2023 Earnings Conference Call February 14, 2023 08:00 ET Company Participants Pravesh Khandelwal - Vice President, Investor Relations Dev Kurdikar - Chief Executive Officer Jake Elguicze - Chief Financial Officer Conference Call Participan...

The following slide deck was published by Embecta Corp. in conjunction with their 2023 Q1 earnings call. For further details see: Embecta Corp. 2023 Q1 - Results - Earnings Call Presentation

Embecta press release ( NASDAQ: EMBC ): Q1 Non-GAAP EPS of $0.96 beats by $0.44 . Revenue of $275.7M (-4.7% Y/Y) beats by $12.8M . Adjusted gross profit and margin of $188.9 million and 68.5%. Adjusted operating income and margin of $101.6 million and 36.9%. ...

PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial results for the three month period ended December 31, 2022. "We are p...

Summary Dividends may not increase every year and a cut or elimination is even possible but the odds are greatly reduced when you diversify among different companies and sectors and focus on dividend quality. The market may move up and down irrationally and seemingly on a whim while our...

PARSIPPANY, N.J., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will participate in the following upcoming investor conferences: 2023 BTIG Medical...

Summary DexCom is young, innovative, admired, and (consequently) highly valued. Embecta is old, lethargic, lacks coverage, and (consequently) lowly valued. Growth and value investors may find respective equities interesting. I use DXCM and EMBC as a lens to view developments in ...

Summary Yacktman's 13F equity portfolio value increased from $9.17B to $10.04B this quarter. Yacktman Asset Management increased Charles Schwab while decreasing PepsiCo, Sysco, and Weatherford International. Yacktman’s largest five stakes are at ~26% of the portfolio. ...

PARSIPPANY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spinoff from Becton, Dickinson and Company (“BD”), today held a grand opening ce...

PARSIPPANY, N.J., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss its fiscal first quarter 2023 financial results, provide an operational update, and...